Results 21 to 30 of about 262,096 (303)

Synthesis and in Vitro and in Vivo Anticoagulant and Antiplatelet Activities of Amidino- and Non-Amidinobenzamides

open access: yesMolecules, 2016
Three amidino- and ten non-amidinobenzamides were synthesized as 3-aminobenzoic acid scaffold-based anticoagulant and antiplatelet compounds. The anticoagulant activities of thirteen synthesized compounds 1–13, and 2b and 3b as prodrugs were preliminary ...
Soo Hyun Lee   +3 more
doaj   +1 more source

Assessment of factors affecting mortality in geriatric patients with warfarin overdose

open access: yesTurkish Journal of Emergency Medicine, 2020
OBJECTIVES: The aim of the present study was to perform a demographic analysis of complications and to determine the factors affecting in-hospital mortality in geriatric patients with warfarin overdose.
Seda Dagar   +3 more
doaj   +1 more source

Anticoagulants [PDF]

open access: yesJournal of Pharmacy and Pharmacology, 1949
Abstract The processes that underly the clotting of blood are still far from adequately understood, in spite of the many facts uncovered by generations of patient investigators. The classical scheme associated with the name of Morawitz1, although neither complete nor universally accepted, is still useful as a summary of the main events ...
openaire   +2 more sources

Anticoagulant Macromolecules

open access: yes, 2023
Anticoagulant macromolecules have gained widespread use in the clinical treatment of cardiovascular diseases, blood-contacting or implantable materials, and medical devices due to their excellent anticoagulant properties.
Jianzhou Niu (16322978)   +9 more
core   +1 more source

Bilateral adrenal hemorrhage [PDF]

open access: yesRomanian Journal of Medical Practice, 2021
Bilateral adrenal hemorrhage represents a challenging condition which requires multi-modal intervention. Our aim to systematically review the published cased diagnosed with this condition. The method we used is based on PubMed database research.
Mihai Cristian Dumitrascu   +6 more
doaj   +1 more source

Major Bleeding Complications and Persistence With Oral Anticoagulation in Non‐Valvular Atrial Fibrillation: Contemporary Findings in Real‐Life Danish Patients

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017
BackgroundThe nonvitamin K antagonist oral anticoagulants have recently become available as an alternative to warfarin as stroke prophylaxis in atrial fibrillation, but data on real‐life patient experience, including bleeding risk, are lacking.
Morten Lamberts   +8 more
doaj   +1 more source

Arum palaestinum delays hepatocellular carcinoma proliferation through the PI3K-AKT-mTOR signaling pathway and exhibits anticoagulant effects with antimicrobial properties

open access: yesFrontiers in Pharmacology, 2023
Background:Arum palaestinum Boiss (AP) is a wild plant in Palestine whose leaves have a long history as food and medicine in Middle Eastern countries. The current study aimed to evaluate the biological characteristics of AP flower extract, including its ...
Majdi Dwikat   +10 more
doaj   +1 more source

Comparison of two reducing agents dithiothreitol and tris(3-hydroxypropyl)phosphine for in vitro kinetic assay of vitamin K epoxide reductase

open access: yesVeterinary and Animal Science, 2020
Vitamin K epoxide reductase (VKOR) is a target enzyme for anticoagulants, such as warfarin, that are used as medicines or rodenticides. Assessing VKOR activity is required to ensure the proper usage of these drugs.
Kazuki Takeda   +4 more
doaj   +1 more source

Venous thromboembolism in COVID 19 infection: Prevalence and practice of prophylaxis - A narrative

open access: yesIndian Journal of Vascular and Endovascular Surgery, 2021
The aims of this review are to ascertain the true prevalence of venous thromboembolism (VTE) in critically ill COVID 19 patients, to explore the strategy regarding prophylaxis and whether intensified prophylaxis is required for critically ill patients ...
U Vasudeva Rao, M D Wasim
doaj   +1 more source

First-In-Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of SHR2285, a Small-Molecule Factor XIa Inhibitor in Healthy Subjects

open access: yesFrontiers in Pharmacology, 2022
Background: Targeting factor XI (FXI) is a promising therapeutic strategy for the treatment and prevention of thrombosis without increasing the risk of bleeding. Here, we assessed the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of SHR2285, a
Rui Chen   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy